Screener
Artiva Biotherapeutics, Inc. ARTV EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | THREE MONTHS ENDED JUNE 30, 2026 | THREE MONTHS ENDED JUNE 30, 2025 | SIX MONTHS ENDED JUNE 30, 2026 | SIX MONTHS ENDED JUNE 30, 2025 |
|---|---|---|---|---|
| Other (expense) income, net | (1) | (5) | 1 | (8) |
| Total other income, net | 1,885 | 1,556 | 2,799 | 3,417 |
| Net loss | $(25,005) | $(21,254) | $(48,521) | $(41,565) |
| Net loss per share, basic and diluted | $(0.63) | $(0.87) | $(1.51) | $(1.71) |
| Weighted-average common shares outstanding, basic and diluted | 39,413,236 | 24,378,823 | 32,086,532 | 24,360,502 |
| Comprehensive loss: | ||||
| Net loss | $(25,005) | $(21,254) | $(48,521) | $(41,565) |
| Other comprehensive (loss) income: |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s EPS (diluted)?
- Artiva Biotherapeutics, Inc. (ARTV) reported EPS (diluted) of -$0.63 in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s EPS (diluted) increased by 27.6% year-over-year, from -$0.87 to -$0.63.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Artiva Biotherapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude